Rheumatoid Arthritis

Archive for the ‘DMARDs Articles’ Category

Ankylosing Spondylitis is an auto-immune disease which affects 2.4 million people in the United States. Agreeing to the Mayo Clinic, “Ankylosing spondylitis is a continuing inflammatory disease that primarily causes pain and inflammation of the joints between the vertebrae of your spine and the joints between your spine and pelvis (sacroiliac joints). However, ankylosing spondylitis may also cause inflammation and pain in other parts of your body as well”. Iritis, a painful inflammation of the eye, is a symptom of ankylosing spondylitis.

The Spondylitis relationship of America has designated April as Spondylitis Awareness Month. This disease is nearly unheard-of by most, even by doctors. The Saa states, “Spondylitis is difficult to diagnose, often taking up to 10 years from the time a inpatient first experiences symptoms to the time the inpatient receives proper diagnosis”.

As person who has experienced Ankylosing Spondylitis and Iritis firsthand on a regular basis for over 25 years, I understand the struggle to receive a proper diagnosis. Laying in bed, unable to move, spine and ribcage stiff, having to have person pull you up by your arms fast to a sitting position, as you scream out in pain, yep, been there done that. It is at those times that house members remember you have ankylosing spondylitis. Someone else time is when the iritis flares up. The pain in the eye is excruciating. An immediate trip to the ophthalmologist is required. You learn real quick to have steroid eye drops on hand!

So what can be done to alleviate these painful symptoms? Medications such as Nsaids (nonsteroidal anti-inflammatory drugs), Dmards (disease modifying anti-rheumatic drugs), and the biologics also called Tnf Blockers, are prescribed to the patient. Exercise, corporeal therapy, good posture practices, and applying heat/cold to relax the muscles and cut joint pain are also suggestions. But after years of accosting my body with all the assorted drugs, I felt there has to be something less toxic. I do visit my chiropractor on a regular basis, which I feel has helped me stay limber. I was still seeking something more.

As a pro advisor and Hypnotherapist, I have been assisting clients talk and visualize their way straight through many ailments. After a painful flair up it came to me, why am I not doing the same for myself? I then set out to originate a hypnotic guided imagery c.d. In order to sooth my aching spine and ribcage. I wrote and recorded my first draft. After listening to the c.d. A few nights I added to it. I then had a “tester”, Someone else person with ankylosing spondylitis, listen. He reported it helped him with his pain. Bravo! I now have the c.d. Out with more “testers” from all over the United States. “Soothing Ankylosing Spondylitis” is the end result.

“Hypnosis has undergone gigantic amounts of scientific testing in modern times. When used in an thorough manner, hypnosis has proven itself to be an productive tool in the supervision of pain and pain perception. Hypnosis is an easy-to-administer course which has no deep or long-lasting side effects, yet most doctors ignore its effectiveness in lieu of more former methods” (Marc Marcuse, University of California).

Hypnosis is not a cure for ankylosing spondylitis, any way it can be utilized to sooth the painful symptoms of this disease. By relaxing the muscles and focusing your awareness on where the imagery is leading you, the listener is able to sense less painful symptoms.Nasa has proven that breaking subconscious patterns takes 30 to 60 days of brain training. As with most hypnotic guided imagery c.d.’s, the listener is encouraged to listen to the c.d. At least once a day for 30 days.

See Also : Buyer advise Anorexia

Rheumatoid arthritis (Ra) is the most form of inflammatory arthritis and affects approximately 2 million Americans. It is a systemic potentially lethal autoimmune disease that affects not only the joints but internal organs as well.

Recent advances in the use of disease modifying anti rheumatic drugs (Dmards) as well as biologic therapies have permitted rheumatologists to perform remission in the majority of patients with Ra.

One medication that is frequently lost in the shuffle and still remains the topic of moot in many circles is prednisone. Prednisone is a glucocorticoid, a group of medicines that have profound anti-inflammatory effects.

Because of this property, rheumatologist frequently employ prednisone as a “bridge” therapy to help with symptoms until the beneficial effects of more potent Dmards and biologic therapies can kick in.

Also, it has been shown that this mixture can also slow down the rate of x-ray progression of joint disease.

The use of prednisone also reduces the need for non-steroidal anti-inflammatory drugs (Nsaids) which themselves carry possible side follow risks for gastrointestinal ulceration as well as increased likelihood of cardiovascular complications, such as stroke and heart attack.

On the flip side, the use of chronic low dose prednisone is not without possible problems. Even in relatively low doses such as 5 mgs a day, prednisone can increase the risk for skin thinning, cataracts, osteoporosis, and other curative problems. One author has reported that using a dose higher than 5 mgs per day can increase the risk for pneumonia.

Many rheumatologists tend to use prednisone in a dose of 7.5-10 mgs a day for 6 months as a bridge. But this undoubtedly isn’t a universal habit. Some rheumatologists use a higher dose, others use prednisone for a much longer period of time and there are some rheumatologists who don’t use prednisone at all.

Personally, I try to keep the dose at 5 mgs per day. When the outpatient is garage and in remission, I also like to begin tapering the prednisone slowly. By slowly, I mean one mg a month.

Prednisone should only be given in the morning. The suspect is that the body’s adrenal glands, which produce glucocorticoids have a diurnal rhythm. The make more glucocorticoid in the morning and less in the evening. By supplying prednisone in a manner that mimics the body’s biology, there is less possible for causing untoward side effects.

This record has focused only on oral prednisone. There are many other steroids that can be injected either directly into the joint or given intravenously. They will be the topic of other article.

Visit : Buyer notice Buyer suggest Thinkbox marketing ATM group

What is arthritis?

Arthritis is a continuing disease that comes with pain and loss of movement of the joints. It is a joint disorder caused by disease, infection, anomalies and other factors that influence the everyday activities. Arthritis affects the citizen of all ages, including children and young adults but ordinarily citizen over 50years show more signs of arthritis because the joint plainly degrades overtime. Arthritis is not a single disease, but a term that covers over 100diseases and medical conditions that can influence many parts of the body. It is a long term disease that cannot be totally cured but can be managed with permissible medical care, sufficient therapy and by treating its symptoms.

However, it should be noted that arthritis is linked with diseases of other tissues and organs in the body and as a supervene it is considered as one of the major causes of disability in citizen who are over 50years and above. In the United States, arthritis is the prominent cause of disability and researchers claimed that nearly 1 in every 5 adults has some form of arthritis.

We have assorted types of arthritis and for this narrative l would like to write on the most base types of arthritis and these are Osteoarthritis and Rheumatoid arthritis.

Osteoarthritis Arthritis – is a disease that can cause the breakdown of joint tissue which leads to joint pain and stiffness. It is normal inflammatory and at onset is subtle and slowly beginning from one or few joints. It is also known as degenerative joint disease, resulting from wear and tear of cartilage ordinarily linked with old age. The pressure of gravity causes damage to the joints and surrounding tissues prominent to pain, tenderness and sometimes swelling at distinct parts of the body.

Rheumatoid arthritis – is a continuing disease potentially disabling type of arthritis that occurs when the body’s immune ideas mistakenly attacks the synovium (cell lining the joint). It ordinarily causes severe joint pain, loss of joint function, stiffness, swelling and sometimes leads to permanent deformity. Rheumatoid arthritis can be difficult to diagnose early because the symptoms can be deceptive. As a supervene no single test can conclusively originate its strict diagnosis. It is responsible for arthritis pain and inflammation joints that affects most joints of the body like fingers, wrists, kneels and toes.

Treatment of Arthritis

Over the years permissible rehabilitation have help to relax arthritis symptoms and strict many serious joint problems. Sometimes physical and occupational therapy is used to control and sound joint mobility and range of motion. The permissible kind and amount of this therapy depends on the underlying cause and private factors.

Arthritis cure largely depends on the type, the severity of the problem and former response to rehabilitation by the patients. As a result, medical management is a must because arthritis like rheumatoid can be crippling and can influence other organs in the body. Doses of aspirin or aspirin-like drugs are base prescription that effectively reduced arthritis pain and inflammation. In case of severe pains, drugs like Dmards or Saards (disease-modifying antirheumatic drugs or slow-acting antirheumatic drugs) such as anti-malaria are administered.

Once again l would like to emphasize that all these drugs prescribed require close management and that most of them have perilous effects, for example in some patients aspirin interferes with platelet function and this can cause serious bleeding.

Finally, in treating arthritis the major concern of the physician is to supply the best rehabilitation that will sell out the pains, or supplementary damage to the joints and forestall any permanent deformity.

Visit : Buyer notice Buyer caution Pheromone Gout

New arthritis medication is now seen by many who suffer from this debilitating disease as their practical rehabilitation option. Presently, there are about 100 kinds of medications being used in the management and rehabilitation of arthritis and associated conditions.

The response, potential side effects and adverse reactions to these medications vary with the individual patient. It is principal for arthritis inpatient to understand their medical options. They should also have the capability to discuss these with their doctors and make informed decisions.

Whatever the type of arthritis, our management and rehabilitation regimen should focus on the following:

* reduce pain and inflammation

* decelerate progression of disease

* Undertake inpatient education

* Minimize therapy risks

* Avoid work disability

* enhance capability of life and functional independence

There are similar goals in the rehabilitation programs using new arthritis medication, but different approaches may be used depending on the diagnosis. The productive management and rehabilitation include:

* approved medication

* Alternative medication and treatment

* healthy diet and food

* adequate rest and exercise

* healthy lifestyle

When you are inspecting new arthritis medication, decision should be based on the diagnosis, severity and response to former therapies.

Upcoming and New Arthritis Medication

Biologics Medications – This medication is a ensue of the complicated interplay among the lymphocytes, the macrophages, and the messenger signals they chronicle with, the cytokines. The mechanism of this type of medication involves a laser-like work up of the immune system. It aims to arrest the progression of tissue damage as a ensue of this autoimmune disease.

Botanical medical Food – It is an Fda-approved prescription medication derived from the bark and root extracts of two botanicals. It belongs to a class of substances called flavonoids. It works by inhibiting the enzyme that causes inflammation. The most promising aspect of this medication is that it does not have the side effects seen in other Nsaids.

Tocilizumab – This new drug is the first humanized interleukin-6 receptor-inhibiting monoclonal antibody to treat rheumatoid arthritis. This is the first drug that is able to inhibit the interleukin-6 receptor, thereby blocking interleukin-6. Its direct ensue is on the immune and inflammatory responses of patients.

Synvisc – This medication is an injectable substance made from rooster cartilage cells. It is marketed as a ‘motor oil’ or lube to the joint. Doctors ordinarily administer a series of 3 to 5 injections. It acts as a shock absorber and lubrication. This medication is well tolerated and easy to administer. It also helps delay surgical operation for those with severe case of arthritis.

Dmard rehabilitation – Disease-modifying antirheumatic drugs (Dmards) are anti-inflammatory drugs for Ra that is used to help relax pain and inflammation. It also helps slow the progression of the disease. There are three new arthritis drugs under this category that are showing a lot of promise. These are etanercept, infliximab, and leflunomide. These are new generation drugs advanced as a ensue of conclusive studies on the patophysiologic and cellular nature of Ra. These medications assault the mechanisms of the disease rather than plainly suppressing the symptoms.

When inspecting new arthritis medications, it principal that you discuss this fully with your doctor. There are any factors that must go into the equation for a good rehabilitation selection using new arthritis medication.

Thanks To : Freedom beach resort Buyer caution ATM group Virtigo

A new study has demonstrated that rheumatoid arthritis (Ra) patients who use tumor necrosis factor (Tnf) blockers are up to four times more likely to fabricate a serious bacterial infection than those who use only methotrexate. While the risk is not tremendously high, it is still a factor that needs to be taken into notice by both patients as well as prescribing rheumatologists.

Infections are base in patients with rheumatoid arthritis and linked disorders, but it is unclear if this is due to the treatments or the underlying disease process. Former studies examining the impact of Tnf blockers on infection have yielded variable results.

The goal of this most new study was to decide if Tnf inhibition raised the risk of serious bacterial infections compared to the use of methotrexate alone.

The study examined 2393 patients treated with Tnf antagonists who were also on Dmards, most often, methotrexate, and 2933 patients taking methotrexate alone. The most base Tnf- blocker used was etanercept (Enbrel), followed by infliximab (Remicade).

During a average follow-up period of 17 months, infection-related hospitalization rates were 2.7% and 2.0% for the Tnf blocker group and methotrexate-only group, respectively.

In order to reason relative risk, researchers often use multivariate determination to fabricate a amount called a hazard ratio. If the amount is less than one, then it means the substance in examine is less dangerous than the control. If the amount equals one, then the substance has the same risk as the control. And if the ratio is greater than one, it means the substance is more dangerous than the control.

Tnf blocker use was linked with a hazard ratio of 1.9 for serious bacterial infection. So, Tnf therapy combined with Dmard therapy is more dangerous than methotrexate alone as far as risk of infection.

The incidence of infections was top within 6 months of initiating Tnf inhibition therapy.

The most base serious infections in both groups were pneumonia/ lung abscess (empyema) followed by cellulitis/soft tissue infection.

The efficacy of Tnfantagonist therapy for most rheumatoid arthritis patients needs to be balanced against the inherent harm of an increased risk of infection linked with these agents. Vigilant monitoring for infection is recommended when using these agents.

(Curtis Jr, Patkar N, Xie A, Martin C, Allison Jj, Saag M, Shatin D, Saag Kg. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists. Arthritis Rheum 2007;56:1125-1133).

Tags : Earning host Freedom beach resort Anorexia